Medscape | DPP-4 Inhibitors and Heart Failure in Diabetes: Be Vigilant Medscape MELBOURNE, Australia — Patients with type 2 diabetes who are at high risk for or who already have heart failure should not be precluded from receiving dipeptidyl peptidase-4 (DPP-4) inhibitor glucose-lowering agents, said most experts at the World ... |
